Evidence map›Paper›PMID 42039618›Full record

ArticlebioRxiv : the preprint server for biology2026

Canonical WNT Ligands Produced by Regulatory T Cells Restrain Effector CD4

Kashish Singh Parihar, Margaret R Niemeier, Igal Ifergan

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kashish Singh PariharDepartment of Immunology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH USA.ORCID 0009-0004-8599-5007
Margaret R NiemeierDepartment of Molecular and Cellular Biosciences, College of Medicine, University of Cincinnati, Cincinnati, OH USA.ORCID 0009-0008-6413-2869
Igal IferganDepartment of Immunology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH USA.ORCID 0000-0003-2945-2580

Funding

Role of the neurovascular molecule Wnt in regulating CNS inflammatory responsesR35GM146890 · NIGMS · UNIVERSITY OF CINCINNATI · PI Igal Ifergan · 2022 to 2026
$2.2M
Role of NK cell subsets in an animal model of relapsing-remittingmultiple sclerosisR03NS144870 · NINDS · UNIVERSITY OF CINCINNATI · PI Igal Ifergan · 2025 to 2026
$162k
NIGMS NIH HHS R35 GM146890NINDS NIH HHS R03 NS144870
6 · The paper itself

Abstract

Regulatory T cells (Tregs) are essential for maintaining immune homeostasis by suppressing excessive activation of effector T cells. Although several mechanisms of Treg-mediated suppression have been described, the molecular signals that contribute to this regulation remain incompletely understood. WNT signaling, best known for its roles in development and tissue homeostasis, has recently emerged as an important regulator of immune function, but its contribution to Treg-mediated immune suppression is largely unknown. Here, we show that Tregs preferentially express multiple canonical WNT ligands, including WNT2B, WNT3, WNT7B, and WNT10B, compared with conventional CD4

Indexed as

CD4+ T cellsFZDimmune suppressionTregsWNT

Identifiers

PMID42039618
PMCPMC13104878

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.